Results 151 to 160 of about 50,638 (234)

Herpes zoster reactivation [PDF]

open access: yesBritish Dental Journal, 2011
M, Ziaei, S A, Aslam, H, Ziaei
openaire   +2 more sources

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang   +3 more
wiley   +1 more source

Factors associated with potentially inappropriate medication use, medication underuse and overuse in older adults in the German National Cohort

open access: yesJournal of Internal Medicine, Volume 299, Issue 6, Page 754-775, June 2026.
Abstract Background Effectively identifying individuals exposed to drug underuse, overuse and potentially inappropriate medication (PIM) in older adults is essential for minimizing preventable drug‐related harms. Methods We analysed data from 54,296 individuals aged 60–74 years from the German National Cohort (NAKO).
Miriam Degen   +18 more
wiley   +1 more source

Sacral Herpes Zoster Mimicking Pressure Ulcers and Causing Elsberg Syndrome. [PDF]

open access: yesClin Case Rep
Yamada J   +5 more
europepmc   +1 more source

Mandibular Herpes Zoster

open access: yesInternal Medicine, 2019
Kosami, Koki, Kenzaka, Tsuneaki
openaire   +3 more sources

Herpes Zoster of the Larynx: A Diagnostic and Therapeutic Challenge. [PDF]

open access: yesCureus
Nogueira N   +4 more
europepmc   +1 more source

Herpes Zoster

open access: yesInternational Journal of Clinical Practice, 1957
openaire   +2 more sources

Epidemiology of herpes zoster at a tertiary care centre in Eastern India. [PDF]

open access: yesBioinformation
Biswas S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy